Cairo Pharmaceuticals
- 208.01 EGP
- -4.18
- -1.97%
Cairo Pharmaceuticals Stock Overview
View Company ProfileStock Summary
| Last Price (EGP) | 208.01 |
| Prev. Close | 212.190 |
| Day Range | 205.01 - 213.99 |
| 52WK range | |
| Turnover (M EGP) | 1.40 |
| Volume (M) | 0.01 |
| Number of Trades | 134 |
| Market Cap (M EGP) | 3,158.62 |
| Change in Market Cap (M EGP) | |
| VWAP (EGP) | 210.49 |
| EPS (TTM) | -- |
| EX-Dividend Date | |
| Dividend | |
| Dividend Yield (%) | |
| Beta | |
| 30D Avg Volume | |
| 30D Avg Turnover(M EGP) | |
| Outstanding Shares | |
| Free Float Shares | |
| Free Float % |
Stock Performance
Stock Highlights
| Highest Market Cap | |
| Date of Highest Mkt. Cap | |
| Lowest Market Cap | |
| Date of Lowest Mkt. Cap |
Earnings Progress
News
More Company News
Pharma stocks lead EGX ahead of potential acquisitions
Cairo – Mubasher: Amid market volatility due to concerns over a second wave of coronavirus (COVID-19) infections, pharmaceutical stocks on the Egyptian...
Kahira Pharmaceuticals’ Q4 profits rise 65%
Cairo – Mubasher: Kahira Pharmaceuticals reported an increase in its profits for the fourth quarter and the fiscal year 2015/16, according to a bourse...
Kahira Pharmaceuticals makes EGP 5.6m profit in December
Cairo – Mubasher: Kahira Pharmaceuticals announced that its profit rose by 17.4% in December, 2015, compared to December, 2014.According to the company’s...
Kahira Pharmaceuticals 4-month profits edge up 5%
Cairo - Mubasher: Kahira Pharmaceuticals reported an increase of 5% to EGP 19.1 million in net profits for the first four months of the fiscal year 2015/16.The...
Kahira Pharmaceuticals profits up 5.5% in year
Cairo-Mubasher: Kahira Pharmaceuticals posted an increase of 5.5% to EGP 43.4 million in net profits for the fiscal year ended July 2015, up from EGP 41.1...
